The Dartmouth Psychiatric Research Center developed and tested the Integrated Dual Disorder Treatment (IDDT) model, an established evidence-based practice designed for people with severe mental health disorders. The Hazelden Co-occurring Disorders Program draws upon the numerous randomized controlled trials using the IDDT model and adapts them for patients with non-severe mental health disorders.

This curriculum is a valuable resource for medical directors and clinicians. It contains vital, current information about the complex issues of medication management, including medication compliance and other psychological concerns of the patient. Issues of differential diagnosis, timing, indications, monitoring, dosage, tolerance and withdrawal, and other topics are considered in this component. Current evidence and consensus-based practices are provided to enable providers to make clinical decisions about medications and their prescription. While many people in peer support groups take psychotropic medication, stigma can still cause some to hide their medication use from others. These issues, and information about the benefits and risks of medications, are also addressed for the patient. Medication Management comes with 40 pages of clinician's instructions, covering topics such as general principles in medication treatment and monitoring symptoms, and a CD-ROM with information sheets on specific medications along with reproducible patient handouts packaged in a three-ring binder.

Learn more about the Hazelden Co-occurring Disorders Program research and history at www.cooccurring.org.